Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • SEC Staff Release Report Concerning Examinations Of Retail Options Order Routing And Execution Practices

    Date 08/03/2007

    The Commission’s staff today released a report summarizing the results of recent examinations and analysis of routing and execution practices in equity options. The “Report Concerning Examinations of Options Order Routing and Execution” can be found on the Commission’s website at http://www.sec.gov/news/studies/2007/optionsroutingreport.pdf.

  • CBOE: Volatility Index (Vix) Options Trade 230,847 Contracts, Setting New All-Time Record Today, Thursday, March 8, 2007

    Date 08/03/2007

    The Chicago Board Options Exchange (CBOE) announced that reported volume in options on the CBOE Volatility Index, "VIX" (ticker symbol VIX), was 230,847 contracts today beating the previous record of 162,856 contracts traded on August 14, 2006. VIX is the widely disseminated benchmark index of market volatility and investor sentiment, sometimes referred to as the market's "fear gauge."

  • Restatement Of Trading Hours For NYBOT Dublin Floor

    Date 08/03/2007

    The New York Board of Trade (NYBOT), a wholly-owned subsidiary of IntercontinentalExchange (NYSE: ICE), announced amendments to its rules which restate the re-open time for financial contracts at the Dublin trading facility in Dublin time instead of New York time to prevent any confusion which could arise from the coming expansion of Daylight Savings Time (DST) in the USA. Effective Friday, March 9, 2007, trading in all financial futures and options contracts will re-open on the Dublin Floor at

  • SIFMA Optimistic About U.S.-China Strategic Economic Dialogue

    Date 08/03/2007

    The Securities Industry and Financial Markets Association (SIFMA) today issued the following statement after U.S. Treasury Secretary Henry Paulson delivered a speech before China’s Shanghai Futures Exchange.

  • SEC Charges Former Drug Manufacturer Executive With Unlawful Insider Trading In Connection With Scheme To Conceal Quality Control Deficiencies

    Date 08/03/2007

    The U.S. Securities and Exchange Commission today simultaneously filed and settled civil charges against Shashikant C. Shah, formerly Vice President of Quality Control, Quality Assurance and Regulatory Affairs of now-defunct generic drug manufacturer Able Laboratories, Inc., alleging that during a 16-month period, Shah reaped $909,000 in profits by selling Able's common stock while possessing material, non-public information about Able's faulty quality control testing practices. Before halting o